Diabetes Pro

ADA American Diabetes Association

Advanced Search Help

Home

Professional Education

Journals

Professional Resources

Research Grants

Recognition Programs

Membership

Webcasts

70th Scientific Sessions (2010)
June 25 - 29, 2010
Orlando, Florida

List of all the Sessions for this Meeting:

A 21st Century Look at Genetic Causes of Diabetes and Its Complications in Youth
A1C Targets in Pediatric Diabetes--Ideal vs. Real
ADA Education Recognition Program--Assessing the Impact of Diabetes Education
Adipose Tissue and Inflammation
Advancing the Field--The Role of Inflammation in Depression and Diabetes (Includes Behavioral Medicine and Psychology Interest Group Award and Lectureship for Distinguished Contributions)
Altered Metabolism During and After a Pregnancy Complicated by Hyperglycemia
Alternative Cellular Sources for Beta Cell Replacement Therapy--Today and Tomorrow
Antigen-Specific and Non-Specific Mechanisms and Treatment of Diabetes
B Cells in Type 1 Diabetes Mellitus
Behavioral Interventions in Diabetes
Beta Cell Failure--The Key to Unlocking Type 2 Diabetes Mellitus
Beta Cell Intracellular Signaling-1--mTor to S6Kinase
Beta Cell Intracellular Signaling-2--PI3Kinase and PKCs, and IKKs
Beta Cell Intracellular Signaling-3--A Potpourri
Beta Cell Stimulus-Secretion Coupling and Metabolism
Beyond the First Phase of Genome-Wide Association Studies (GWAS)
Bile Acids as Metabolic Regulators
Brown Adipose Tissue
Cardiorenal Issues in Diabetes Management
Cardiovascular Complications of Diabetes
Cardiovascular Disease and Diabetes--Nutrition Update
Cardiovascular Disease in Diabetes
Cardiovascular Risks of Hypoglycemia
Cellular Mechanisms of Cardiovascular Complications of Diabetes
Central Modulators of Obesity
Clinical Decision Making in the Era of GLP-1 Agonists: Are You An Early or Late Adopter?
Clinical Impact of the New Genetic Discoveries in Diabetes
Clinical Role of TZDs in 2010
Clues to Mechanisms of Insulin Resistance from Other Human Syndromes
Combination Therapies for Type 2 Diabetes From the Get-Go--Are We There Yet?
Complications of Diabetes--What Is Unique about the Retina?
Continuous Glucose Monitoring
Control of Adipose Tissue Development and Function
Controversies in Blockade of the Renin-Angiotensin-Aldosterone System (RAAS)
Controversies Relating Cancer with Diabetes, Obesity, and Insulin
Cross-Talk in Insulin Signaling at the Cellular Level
Deficiencies in Diabetes Care and Outcomes - Exploring Problem Areas and Emerging Solutions
Diabetes Diagnosis Based on the A1C
Diabetes in the New Realm of Comparative Effectiveness Research (CER)
Diabetes Outcomes and Related Conditions
Diabetes Prevention and Behavioral Interventions in Underserved Populations
Diabetic Dyslipidemia
Dietary Sweeteners Containing Fructose--Effects on Metabolism and Impact in the Food Supply
Does Autoimmunity Influence Beta Cell Regeneration?
Does Diabetes Affect the Approach to Diagnosis or Management of Cardiovascular Disease?
Drug Therapy during Pregnancy--Safety and Effectiveness
Epidemiology of Type 1 and Type 2 Diabetes
Epigenetics and Metabolic Disease
Etiology of Type 2 Diabetes
Exercise and Diabetes
Foot Complications
From Children to Adults--Models of Transition Care in Youth with Diabetes
From Genetic Association to Molecular Mechanism
Genetic Risks and Gene Specific Studies
Genome Wide Genetics
Glycemic Outcomes and Acute Complications--MDI or the Pump--Which Is Best?
HEALTHY Study--Middle School-Based Intervention to Reduce Diabetes Risk
How To Train Your Dragon: Optimizing the PCP Relationship
Hypoglycemia
Implications of the NAVIGATOR Trial for Prevention of Diabetes and Cardiovascular Disease in Subjects with Impaired Glucose Tolerance
Improving Islet Transplantation
Incretin and Leptin Biology
Incretin Comparisons
Inflammation in Glucose Homeostasis
Insulin Action--A Molecular View
Insulin Delivery Systems
Insulin Secretion
Insulin Secretion - In Vivo
Insulin Therapy
Integrated Physiology - Liver
Integrated Physiology - Muscle
Integrating Complementary Practices into Diabetes Care--Herbs, Supplements, and Mindful Meditation
Intensive Insulin Therapy at the Onset of Type 2 Diabetes--Can We Preserve Beta Cell Function and Reverse Diabetes?
Interest Group Discussion on Behavioral Medicine and Psychology
Interest Group Discussion on Clinical Endocrinology, Health Care Delivery, and Public Heath
Interest Group Discussion on Diabetes in Youth
Interest Group Discussion on Education
Interest Group Discussion on Epidemiology and Statistics
Interest Group Discussion on Nutritional Science and Metabolism
Interest Group Discussion on Pregnancy and Reproductive Health
Is Diabetes Really a Cardiovascular Disease Equivalent?
Is the Patient with Well-Managed Type 1 Diabetes Still at Increased Risk for Cardiovascular Disease?
Islet Development and Signal Transduction
Joint ADA/AACC Symposium--Point of Care Devices for Glucose and HbA1C--Are They Up to the Task?
Joint ADA/EASD Symposium--Glucagon-Like Peptide-1--From Secretion to Function
Joint ADA/JDRF Symposium--The Artificial Pancreas--A Goal within Reach?
Joint ADA/The Lancet Symposium
Kelly West Lecture
Late Breaking Clinical Studies
Life and Death in the Islet I
Life and Death in the Islet II
Lipids--Key Issues in the Management of Dyslipidemia
Lost in Translation
Managing Insulin Therapy in the Obese, Extremely Insulin Resistant Patient
Maximizing Diabetes Care--Shared Medical Appointments
Mechanisms of In Vivo Insulin Action
Mitochondria and Energy Homeostasis
Mitochondria, Endoplasmic Reticulum (ER) and Oxidative Stress, and Beta Cell Survival
Mitochondrial Metabolism and Substrate Selection
Molecular Mechanisms of Insulin Resistance/Action
Monitoring and Clinical Impact of Islet Transplantation
Nanotechnology and Tissue Engineering for Beta Cell Replacement Therapy
National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture
NDEP Symposium--Translating New Research into a Public Health Campaign and Tools for Supporting Behavior Change
Neuropathy
New Technologies for Diabetes Education
Newer Insulins--As They Approach Availability What Should We Know about Them?
NIDDK Symposium--Novel Pathways to Treatment of Type 2 Diabetes and Obesity
Non-Caloric/Non-Nutritive Sweeteners--What's New?
Novel Approaches to Patient and Provider Education
Novel Immune Mechanisms in Diabetes
Novel Insights into Insulin Resistance and Metabolic Syndrome
Novel Mechanisms in the Development of Diabetic Nephropathy
Nutrient-Gut-Brain Modulators
Nutrition
Obesity - Animal
Obesity - Human
Obesity - Human Pathophysiology and Treatment
Obesity and Type 2 Diabetes in Youth
Ocular
Pathways to Beta Cell Development and Differentiation
Pediatric Diabetes - Clinical Aspects of Beta Cell Function
Pediatric Diabetes - New Clinical Measurements, Approaches and Outcomes
Pediatric Diabetes Trends--Epidemiology 2010
Pharmacotherapies for the Treatment of Type 2 Diabetes - From the Old to the New
Physiological Aspects of Hypoglycemia
Practical Issues in Diabetes and Exercise
Prediction and Natural History of Type 1 Diabetes
Pregnancy and Diabetes Research--A 20-Year Tribute to Norbert Freinkel (Includes Norbert Freinkel Lecture)
Pregnancy Diet and Supplements--Needs and Concerns
Prescribing Exercise for Severely Obese Patients
President, Health Care & Education Address and Outstanding Educator in Diabetes Award Lecture
President, Medicine & Science Address and Banting Lecture
Results of the ACCORD Clinical Trial
Role of the Kidney in the Pathogenesis of Type 2 Diabetes Mellitus
Selective Hepatic Insulin Resistance
Should New Diabetes Drugs Submitted to the FDA Have a Higher Bar for Cardiovascular Safety Than Other Drugs?
Signal Transduction
Society for Clinical Trials Symposium--Issues in the Design, Conduct, and Analysis of Large Randomized Clinical Trials in Diabetes
Stages of the Lifecycle and Risk for Onset and Progression of Diabetes and Its Complications
Tactics and Controversies in the Management of Hyperglycemia in the Hospital
Tailoring Diabetes Treatment Priorities in the New Age of Cardiometabolic Risk Management
Targeting and Tailoring - Keys to Maximizing Health and Economic Outcomes in Diabetes Care and Prevention
Team Building to Prevent Amputations
The Art and Science of Gestational Diabetes Counseling
The Effects of Obesity, Excessive Gestational Weight Gain, and Hyperglycemia on Pregnancy Metabolism and the Fetus
The Implications of U.S. Health Care Reform on the Care and Prevention of Diabetes
The Potential of SGLT-2 Inhibitors for Diabetes Management
The Role of Sex Hormones in the Epidemiology of Type 2 Diabetes and Cardiometabolic Risk
Thyroid Hormone Signaling in Insulin Action and Metabolism
Transdifferentiation and Reprogramming
Type 2 Diabetes, Exercise, and Cerebrovascular Physiology
Update on BARI 2D - Treatment of Insulin Resistance
Update on Diabetic Peripheral Neuropathy
Updates on GLP-1 Agonists
Vascular, Infection, Pressure--The VIPs of Healing Diabetic Wounds
What Has Genetics Taught Us? From Gene to Human Physiology
What Influences How Much We Eat?
Will DPP-4 Inhibitors Replace Sulfonylureas?
Addressing the Needs of Patients with T2DM with GLP-1 Agonists: A Case-Based Program Supported by an unrestricted educational grant from Novo Nordisk, Inc.
Camino a la Meta: El surgimiento de nuevas terapias para la diabetes tipo 2 Supported by an unrestricted educational grant from Novo Nordisk, Inc.
Clinical Challenges: Addressing Hyperglycemia in Non-Critically Ill Patients from Hospital to Home - A Case-based Interactive Program Supported by an unrestricted educational grant from Eli Lilly and Company
In Reach of a Cure for Diabetes: Advances in Metabolic Surgery and "Closing the Loop" Supported by an unrestricted educational grant from Animas Corporation and Ethicon Endo-Surgery, Inc.
Looking Beyond Glucose Control in Type 2 Diabetes: The Cardiovascular, Cardioprotective and Weight Effects of GLP-1 Supported by an unrestricted educational grant from Amylin Pharmaceuticals, Inc. and Lilly USA LLC
Medical Crossfire "Beyond Insulin: A New Target for Diabetes Management Based on Glucose Reabsorption in the Kidneys" Supported by an unrestricted educational grant from Bristol-Myers Squibb & AstraZeneca
Multifactorial Risk Reduction to Improve the Management of Type 2 Diabetes: Taking Advantage of Combination Therapy Supported by an unrestricted educational grant from Daiichi Sankyo, Inc.
Overcoming Barriers to Glycemic Control: What Have We Learned and Where Do We Need to Be? Supported by an unresticted educational grant from Merck & Co., Inc.
Spotlight on Insulin Analogs: Clinical Evidence for Individualized Care

Refine Your Search

Title:

Speaker:

Session:

Search Text:

Meeting:

Diabetes Pro

ADA American Diabetes Association

Webcasts

Related Content

Refine Your Search $(function () { $(".SearchTips").tipTip({ defaultPosition: "right", maxWidth: "auto" }); });

Refine Your Search